Esomeprazole and omeprazole may well boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in greater adverse effects including drowsiness, although the clinical relevance is reduced in most patients – monitor the client for adverse effects (e.The purpose of this review was to evaluate the anxiolytic, sedative, and